Vol 2 (September 2018): Annals of Infection

Editorial

Biomarkers for Lassa fever outcome?

Kyle Rosenke, David Safronetz, Heinz Feldmann

Annals of Infection

2018;

2:

4

(26 September 2018)

PDF Full Text (3202) COI Form Open Access

Editorial

Second-line antiretroviral therapy in resource-limited settings: what we know and the challenges of ever-changing antiretroviral therapy

Diganth Ningappa, Ann C. Collier

Annals of Infection

2018;

2:

3

(26 September 2018)

PDF Full Text (3149) COI Form Open Access